Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,292 | -12,485 | -10,104 | -26,067 | -21,151 |
| Depreciation Amortization | 7,700 | 449 | 288 | 380 | 513 |
| Accounts receivable | -1,521 | 1,346 | 28 | 726 | -2,716 |
| Accounts payable and accrued liabilities | -1,371 | 1,681 | -867 | -34 | -683 |
| Other Working Capital | -5,440 | -274 | -3,798 | -2,347 | -4,021 |
| Other Operating Activity | 7,010 | -3,797 | 6,170 | 6,943 | 5,582 |
| Operating Cash Flow | $-7,914 | $-13,081 | $-8,284 | $-20,399 | $-22,477 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -102 | -16 | -83 | -582 | -358 |
| Purchase Sale Intangibles | N/A | -33,000 | N/A | 300 | N/A |
| Other Investing Activity | 0 | -33,000 | 0 | 300 | 0 |
| Investing Cash Flow | $-102 | $-33,016 | $-83 | $-282 | $-358 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 40,000 | N/A | 3,000 | 14,250 |
| Debt Repayment | N/A | -5,391 | -10,959 | N/A | -1,196 |
| Common Stock Issued | 63 | 29,788 | 8 | 6,610 | 35,799 |
| Common Stock Repurchased | -27 | -27 | N/A | N/A | N/A |
| Dividend Paid | -77 | -161 | -163 | -163 | -178 |
| Other Financing Activity | 0 | 0 | 6,900 | 0 | 0 |
| Financing Cash Flow | $-41 | $64,208 | $-4,213 | $9,447 | $48,675 |
| Exchange Rate Effect | 9 | 22 | -65 | 50 | 107 |
| Beginning Cash Position | 25,270 | 7,137 | 19,782 | 30,966 | 5,018 |
| End Cash Position | 17,222 | 25,270 | 7,137 | 19,782 | 30,966 |
| Net Cash Flow | $-8,049 | $18,134 | $-12,645 | $-11,184 | $25,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,914 | -13,081 | -8,284 | -20,399 | -22,477 |
| Capital Expenditure | -102 | -16 | -83 | -582 | -358 |
| Free Cash Flow | -8,016 | -13,097 | -8,367 | -20,982 | -22,835 |